12:00 AM
 | 
Feb 06, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Vivitrol naltrexone: Phase IV started

Alkermes began an open-label, U.S. Phase IV trial to evaluate intramuscular injections of 380 mg Vivitrol in 30 adult criminal offenders with a prior history of opioid dependence who are seeking treatment. Subjects...

Read the full 142 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >